Transforming growth factor β(1) genotype and change in left ventricular mass during antihypertensive treatment–results from the swedish irbesartan left ventricular hypertrophy investigation versus atenolol (Silvhia)

Background: Angiotensin II, via the angiotensin II type 1 (AT1) receptor, may mediate myocardial fibrosis and myocyte hypertrophy seen in hypertensive left ventricular (LV) hypertrophy through production of transforming growth factor β(1)(TGF‐β(1)); AT1‐receptor antagonists reverse these changes. Th...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Cardiol
Main Authors: Hallberg, Pär, Lind, Lars, Billberger, Katarina, Michaelsson, Karl, Karlsson, Julia, Kurland, Lisa, Kahan, Thomas, Malmqvist, Karin, Öhman, K. Peter, Nyström, Fredrik, Liljedahl, Ulrika, Syvänen, Ann‐Christine, Melhus, Håkan
Formato: Artigo
Idioma:Inglês
Publicado: Wiley Periodicals, Inc. 2006
Assuntos:
Clinical Investigations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6654118/
https://ncbi.nlm.nih.gov/pubmed/15049387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960270315
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares